2015
DOI: 10.1016/j.actbio.2015.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Reprint of: Extracellular matrix as a biological scaffold material: Structure and function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
91
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 449 publications
(91 citation statements)
references
References 113 publications
0
91
0
Order By: Relevance
“…To date, clinical application with decellularized ECM has included acellular administration, mainly in the form of ECM sheets as surgical patches [90, 91], and recently the initiation of a clinical trial with an injectable cardiac ECM derived hydrogel (clinicaltrials.gov identifier NCT02305602). The acellular route is undoubtedly easier in terms of translation and has the potential to modulate the fate of endogenous progenitor cells.…”
Section: Current Challenges and Future Opportunitiesmentioning
confidence: 99%
“…To date, clinical application with decellularized ECM has included acellular administration, mainly in the form of ECM sheets as surgical patches [90, 91], and recently the initiation of a clinical trial with an injectable cardiac ECM derived hydrogel (clinicaltrials.gov identifier NCT02305602). The acellular route is undoubtedly easier in terms of translation and has the potential to modulate the fate of endogenous progenitor cells.…”
Section: Current Challenges and Future Opportunitiesmentioning
confidence: 99%
“…9 For example, the release of cytokines and growth factors, with basic fibroblast growth factor (bFGF) and transforming growth factor (TGF)- μ 1 being the most abundant, 29 may play important roles in promoting cell proliferation, matrix production, and angiogenesis. These bioactive factors may account for at least some of the positive effects observed with MatriStem in the current study.…”
Section: Commentmentioning
confidence: 99%
“…It has been shown that these grafts, when placed in the appropriate micro- and loading environments, can promote site-specific functional tissue remodeling by limiting destructive inflammatory responses, recruiting requisite cell populations including progenitor cells, and supporting cell attachment, proliferation, and matrix production. 9,10 …”
Section: Introductionmentioning
confidence: 99%
“…9 For example, the release of cytokines and growth factors, with basic fibroblast growth factor (bFGF) and transforming growth factor (TGF)-μ1 being the most abundant, 29 may play important roles in promoting cell proliferation, matrix production, and angiogenesis. These bioactive factors may account for at least some of the positive effects observed with MatriStem in the current study.…”
Section: Commentmentioning
confidence: 99%
“…It has been shown that these grafts, when placed in the appropriate micro-and loading environments, can promote site-specific functional tissue remodeling by limiting destructive inflammatory responses, recruiting requisite cell populations including progenitor cells, and supporting cell attachment, proliferation, and matrix production. 9,10 We chose to use MatriStem Surgical Matrix RS (MatriStem RS, ACell Inc, Columbia, MD), a noncross-linked degradable acellular porcine urinary bladder matrix, because it facilitates reconstructive remodeling of smooth muscle and connective tissue as shown in its application in cardiac defect repair, esophagus reinforcement, and chronic wound repairs. [11][12][13][14] It is important to distinguish regenerative matrices such as MatriStem (noncross-linked) from biologic materials that have been chemically cross-linked (eg, Pelvicol, Bard, Murray Hill, NJ) to provide mechanical support similar to polypropylene mesh.…”
Section: Introductionmentioning
confidence: 99%